Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 781621, 10 pages
http://dx.doi.org/10.1155/2010/781621
Review Article

Current Status and Future Prospects of Proton MR Spectroscopy of the Breast with a 1.5T MR Unit

1Breast Center, Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba 296-8602, Japan
2Siemens Japan K.K. Healthcare Sector, 3-20-14 Higashi-Gotanda, Shinagawa-ku, Tokyo 141-8644, Japan

Received 30 April 2010; Accepted 1 September 2010

Academic Editor: Massimo Aglietta

Copyright © 2010 Mitsuhiro Tozaki and Katsuya Maruyama. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. ACR Practice guideline for the performance of contrast-enhanced magnetic resonance imaging (MRI) of the breast, www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/breast.aspx.
  2. R. M. Mann, C. K. Kuhl, K. Kinkel, and C. Boetes, “Breast MRI: guidelines from the European Society of Breast Imaging,” European Radiology, vol. 18, no. 7, pp. 1307–1318, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. K. Glunde, C. Jie, and Z. M. Bhujwalla, “Molecalar causes of tile aberrant choline phospholipid metabolism in breast cancer,” Cancer Research, vol. 64, no. 12, pp. 4270–4276, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. P. Stanwell, L. Gluch, D. Clark et al., “Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T,” European Radiology, vol. 15, no. 5, pp. 1037–1043, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. K. A. Kvistad, I. J. Bakken, I. S. Gribbestad et al., “Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy,” Journal of Magnetic Resonance Imaging, vol. 10, no. 2, pp. 159–164, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Tozaki, “Proton MR spectroscopy of the breast,” Breast Cancer, vol. 15, no. 3, pp. 218–223, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. P. A. Bottomley, “On restoring motion-induced signal loss in single-voxel magnetic resonance spectra,” Magnetic Resonance in Medicine, vol. 508, pp. 333–348, 1987. View at Google Scholar
  8. P. Stanwell and C. Mountford, “In vivo proton MR spectroscopy of the breast,” Radiographics, vol. 27, pp. S253–S266, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. J. Star-Lack, S. J. Nelson, J. Kurhanewicz, L. R. Huang, and D. B. Vigneron, “Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING),” Magnetic Resonance in Medicine, vol. 38, no. 2, pp. 311–321, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Haase, J. Frahm, W. Hanicke, and D. Matthaei, “1H NMR chemical shift selective (CHESS) imaging,” Plasma Sources Science and Technology, vol. 30, no. 4, pp. 341–344, 1985. View at Publisher · View at Google Scholar · View at Scopus
  11. P. J. Bolan, S. Meisamy, E. H. Baker et al., “In vivo quantification of choline compounds in the breast with 1H MR spectroscopy,” Magnetic Resonance in Medicine, vol. 50, no. 6, pp. 1134–1143, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. I. J. Bakken, I. S. Gribbestad, T. E. Singstad, and K. A. Kvistad, “External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla,” Magnetic Resonance in Medicine, vol. 46, no. 1, pp. 189–192, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. H.-M. Baek, J.-H. Chen, K. Nie et al., “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology, vol. 251, no. 3, pp. 653–662, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. H.-M. Baik, M.-Y. Su, H. Yu, O. Nalcioglu, and R. Mehta, “Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T,” Magnetic Resonance Materials in Physics, Biology and Medicine, vol. 19, no. 2, pp. 96–104, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. W. Huang, P. R. Fisher, K. Dulaimy, L. A. Tudorica, B. O'Hea, and T. M. Button, “Detection of breast malignancy: diagnostic MR protocol for improved specificity,” Radiology, vol. 232, no. 2, pp. 585–591, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. L. Bartella, E. A. Morris, D. D. Dershaw et al., “Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study,” Radiology, vol. 239, no. 3, pp. 686–692, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. R. Roebuck, K. M. Cecil, M. D. Schnall, and R. E. Lenkinski, “Human breast lesions: characterization with proton MR spectroscopy,” Radiology, vol. 209, no. 1, pp. 269–275, 1998. View at Google Scholar · View at Scopus
  18. K. M. Cecil, M. D. Schnall, E. S. Siegelman, and R. E. Lenkinski, “The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy,” Breast Cancer Research and Treatment, vol. 68, no. 1, pp. 45–54, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. D. K. W. Yeung, H. S. Cheung, and G. M. K. Tse, “Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy–initial results,” Radiology, vol. 220, no. 1, pp. 40–46, 2001. View at Google Scholar · View at Scopus
  20. N. R. Jagannathan, M. Kumar, V. Seenu et al., “Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer,” British Journal of Cancer, vol. 84, no. 8, pp. 1016–1022, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. G. M. K. Tse, H. S. Cheung, L.-M. Pang et al., “Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors,” American Journal of Roentgenology, vol. 181, no. 5, pp. 1267–1272, 2003. View at Google Scholar · View at Scopus
  22. F. Sardanelli, A. Fausto, G. Di Leo, R. De Nijs, M. Vorbuchner, and F. Podo, “In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy,” American Journal of Roentgenology, vol. 192, no. 6, pp. 1608–1617, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. Tozaki and E. Fukuma, “1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?” American Journal of Roentgenology, vol. 193, no. 3, pp. 840–849, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. American College of Radiology, Breast Imaging Reporting and Data System (BI-RADS), American College of Radiology, Reston, Va, USA, 4th edition, 2003.
  25. L. Bartella, S. B. Thakur, E. A. Morris et al., “Enhancing nonmass lesions in the breast: evaluation with proton ( 1H) MR spectroscopy,” Radiology, vol. 245, no. 1, pp. 80–87, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. H.-M. Baek, J.-H. Chen, H. J. Yu, R. Mehta, O. Nalcioglu, and M.-Y. Su, “Detection of choline signal in human breast lesions with chemical-shift imaging,” Journal of Magnetic Resonance Imaging, vol. 27, no. 5, pp. 1114–1121, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. R. E. Lenkinski, X. Wang, M. Elian, and S. N. Goldberg, “Interaction of gadolinium-based MR contrast agents with choline: implications for MR spectroscopy (MRS) of the breast,” Magnetic Resonance in Medicine, vol. 61, no. 6, pp. 1286–1292, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. C. Lean, S. Doran, R. L. Somorjai et al., “Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy,” Technology in Cancer Research and Treatment, vol. 3, no. 6, pp. 551–556, 2004. View at Google Scholar · View at Scopus
  29. M. Tozaki and K. Hoshi, “1H MR spectroscopy of invasive ductal carcinoma: correlations with FDG PET and histological prognostic factors,” American Journal of Roentgenology, vol. 194, pp. 1384–1390, 2010. View at Google Scholar
  30. M. Tozaki, T. Kobayashi, S. Uno et al., “Breast-conserving surgery after chemotherapy: value of MDCT for determining tumor distribution and shrinkage pattern,” American Journal of Roentgenology, vol. 186, no. 2, pp. 431–439, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. P. T. Weatherall, G. F. Evans, G. J. Metzger, M. H. Saborrian, and A. M. Leitch, “MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation,” Journal of Magnetic Resonance Imaging, vol. 13, no. 6, pp. 868–875, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. S. C. Partridge, J. E. Gibbs, Y. Lu, L. J. Esserman, D. Sudilovsky, and N. M. Hylton, “Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy,” American Journal of Roentgenology, vol. 179, no. 5, pp. 1193–1199, 2002. View at Google Scholar · View at Scopus
  33. E. Yeh, P. Slanetz, D. B. Kopans et al., “Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer,” American Journal of Roentgenology, vol. 184, no. 3, pp. 868–877, 2005. View at Google Scholar · View at Scopus
  34. A. A. Tardivon, L. Ollivier, C. Khoury, and F. Thibault, “Monitoring therapeutic efficacy in breast carcinomas,” European Radiology, vol. 16, no. 11, pp. 2549–2558, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. N. R. Jagannathan, M. Kumar, V. Seenu et al., “Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer,” British Journal of Cancer, vol. 84, no. 8, pp. 1016–1022, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. S. Meisamy, P. J. Bolan, E. H. Baker et al., “Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy–a pilot study at 4 T,” Radiology, vol. 233, no. 2, pp. 424–431, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. M. Kumar, N. R. Jagannathan, V. Seenu, S. N. Dwivedi, P. K. Julka, and G. K. Rath, “Monitoring the therapeutic response of locally advanced breast cancer patients: sequential in vivo proton MR spectroscopy study,” Journal of Magnetic Resonance Imaging, vol. 24, no. 2, pp. 325–332, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. D. J. Manton, A. Chaturvedi, A. Hubbard et al., “Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy,” British Journal of Cancer, vol. 94, no. 3, pp. 427–435, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. M. Tozaki, M. Sakamoto, Y. Oyama et al., “Monitoring of early response to neoadjuvant chemotherapy in breast cancer with 1H MR spectroscopy: comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography,” Journal of Magnetic Resonance Imaging, vol. 28, no. 2, pp. 420–427, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. H.-M. Baek, J.-H. Chen, K. Nie et al., “Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy,” Radiology, vol. 251, no. 3, pp. 653–662, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. M. Tozaki, “What is best for early response to chemotherapy: size, curve, diffusion, spectroscopy, PET?” European Radiology, vol. 19, pp. S944–S946, 2009. View at Google Scholar
  42. M. Tozaki, Y. Oyama, and E. Fukuma, “Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H MR spectroscopy with diffusion MR imaging,” Japanese Journal of Radiology, vol. 28, pp. 101–109, 2010. View at Google Scholar
  43. M. Tozaki, M. Sakamoto, Y. Oyama, K. Maruyama, and E. Fukuma, “Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method,” Journal of Magnetic Resonance Imaging, vol. 31, pp. 895–902, 2010. View at Google Scholar
  44. C. Rousseau, A. Devillers, C. Sagan et al., “Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography,” Journal of Clinical Oncology, vol. 24, no. 34, pp. 5366–5372, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus